Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
The Analytical Advantage Across The Development Lifecycle
Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
-
Screening For Amorphous Drug Substance
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
What Everyone Needs To Know About Polymorphs
Build a strong foundation in solid form science — especially polymorphism — to reduce risk, control variability, and accelerate your path from development to reliable, cost-effective manufacturing.
-
Amorphous Solids: Implications For Solubility And Stability
Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
From 51% Yield To 87% With Targeted Impurity Removal
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
Producing Quality APIs At Scale
Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.
-
Integrating High-Content Imaging With Traditional Plate-Based Screening
Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.
-
Accelerating Discovery Success With Structure-Guided Drug Design
Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.
-
Predicting Performance Of Lotions Through Rheological Characterization
Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.
FORMULATION DEVELOPMENT SOLUTIONS
- Largest Global Network Of Harmonized GMP Product Testing Laboratories
- Emulate Contract Research Services
- Trusted End-To-End CDMO Partner For Your Journey
- Simplify Your Single Cell Workflow Like Never Before
- Optimize Protein Purification Using Filtration Solutions
- Drug Delivery Materials
- Compact And Tunable Absorbance Microplate Readers
- Colon Intestine Bio-Kit
- Translational Pharmaceutics® For First-In-Human Studies
- MaxPeak Premier For Glycan Analysis
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Compact & Powerful Double Planetary Mixer For Lab And Pilot-Scaling
- METTLER TOLEDO Strengthens Its Portfolio In The Americas And Europe With Eagle
- AES Cleanroom Technology appoints John Groth As Chief Revenue Officer
- Navigating Change: Key Industry Insights At PHARMAP 2026
- AbbVie Announces $1.4 Billion North Carolina Campus To Expand U.S. Pharmaceutical Manufacturing Capacity
- Contec, Inc.® Partners With i-team Global To Deliver Cleanroom-Certified, Battery-Powered Mechanized Cleaning System
- MECART Releases Highlights Of Peer-Reviewed Study Assessing Cleanroom Life-Cycle Environmental Impacts
- CDMO Nucleus RadioPharma Secures $50 Million Financing From OrbiMed to Expand Manufacturing Capacity
- Antares Vision Group To Present Denester-Inspection-Labeling Line For Prefilled Syringes At INTERPHEX 2026 Conference
- Achieve Life Sciences Announces Operational Progress Including Completion Of Technology Transfer To Adare Pharma Solutions